Cash Flow Statement
Growth Metrics

Mimedx (MDXG) EBIT Margin (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,505.00
Dec 31, 2025 -166.00
Sep 30, 2025 697.00
Jun 30, 2025 319.00
Mar 31, 2025 -254.00
Dec 31, 2024 -138.00
Sep 30, 2024 -1,361.00
Jun 30, 2024 1,131.00
Mar 31, 2024 -226.00
Dec 31, 2023 423.00
Sep 30, 2023 27.00
Jun 30, 2023 1,381.00
Mar 31, 2023 -1,568.00
Dec 31, 2022 2,570.00
Sep 30, 2022 391.00
Jun 30, 2022 138.00
Mar 31, 2022 -1,832.00
Dec 31, 2021 423.00
Sep 30, 2021 -110.00
Jun 30, 2021 1,082.00
Mar 31, 2021 1,205.00
Dec 31, 2020 -838.00
Sep 30, 2020 -418.00
Jun 30, 2020 1,135.00
Mar 31, 2020 -1,589.00
Dec 31, 2019 -2,235.00
Sep 30, 2019 4,129.00
Jun 30, 2019 -516.00
Mar 31, 2019 -1,050.00
Dec 31, 2018 -1,009.00
Sep 30, 2018 -133.00
Jun 30, 2018 -178.00
Mar 31, 2018 -2,377.00
Dec 31, 2017 1,677.00
Sep 30, 2017 156.00
Jun 30, 2017 -3.00
Mar 31, 2017 2,165.00
Dec 31, 2016 -1,996.00
Sep 30, 2016 109.00
Jun 30, 2016 346.00
Mar 31, 2016 -1,220.00
Dec 31, 2015 126.00
Sep 30, 2015 132.00
Jun 30, 2015 196.00
Mar 31, 2015 -134.00
Dec 31, 2014 62.00
Sep 30, 2014 1,266.00
Jun 30, 2014 302.00
Mar 31, 2014 329.00
Dec 31, 2013 -626.00
Sep 30, 2013 392.00
Jun 30, 2013 -354.00
Mar 31, 2013 729.00
Dec 31, 2012 3,644.00
Sep 30, 2012 -4,329.00
Jun 30, 2012 1,463.00
Mar 31, 2012 7,539.00
Dec 31, 2011 -1,565.00
Sep 30, 2011 4,846.00
Jun 30, 2011 18,682.00